Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Fertil Steril ; 107(1): 269-275, 2017 01.
Artículo en Inglés | MEDLINE | ID: mdl-27816236

RESUMEN

OBJECTIVE: To study the role of micro-RNA (miRNA)-200b and miRNA-429 in human ovulation and to measure their expression levels in ovulatory and anovulatory patients. DESIGN: Micro-RNA-200b and miRNA-429 expression analysis in human serum and granulosa cells at different phases of the ovulation cycle in normal cycling women and women undergoing assisted reproductive technology cycles. SETTING: University-affiliated hospital and academic research laboratory. PATIENT(S): Forty women (7 normally ovulating, 15 normally ovulating with pure male infertility factor, and 18 with polycystic ovary syndrome) were included in this study. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): The expression profile of circulating miRNAs and granulosa cells was assessed by means of real-time quantitative reverse transcription-polymerase chain reaction analysis. RESULT(S): We identified miRNA-200b and miRNA-429 in the sera of all women tested. These miRNA expression levels were elevated during the early follicular phase of the cycle compared with serum levels during the early luteal phase. Anovulatory women, diagnosed with polycystic ovary syndrome, expressed significantly higher levels of miRNA-200b and miRNA-429 compared with spontaneously ovulating women. Ovulation induction with exogenous gonadotropins during an IVF cycle reduced these levels to the levels measured in normal ovulating women. CONCLUSION(S): Our findings suggest an involvement of miRNA-200b and miRNA-429 in the pituitary regulation of human ovulation. Although it is unclear whether this altered miRNA expression profile is a cause or a result of anovulation, the levels of these molecules in the serum of anovulatory women may serve as serum biomarkers for the ovulation process.


Asunto(s)
Anovulación/sangre , Infertilidad Femenina/sangre , MicroARNs/sangre , Ovulación , Síndrome del Ovario Poliquístico/sangre , Adulto , Anovulación/genética , Anovulación/fisiopatología , Anovulación/terapia , Estudios de Casos y Controles , Femenino , Fármacos para la Fertilidad Femenina/administración & dosificación , Fertilización In Vitro , Marcadores Genéticos , Gonadotropinas/administración & dosificación , Células de la Granulosa/química , Hospitales Universitarios , Humanos , Infertilidad Femenina/genética , Infertilidad Femenina/fisiopatología , Infertilidad Femenina/terapia , Masculino , Ciclo Menstrual , MicroARNs/genética , Ovulación/efectos de los fármacos , Ovulación/genética , Inducción de la Ovulación , Síndrome del Ovario Poliquístico/genética , Síndrome del Ovario Poliquístico/fisiopatología , Embarazo , Reacción en Cadena en Tiempo Real de la Polimerasa , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Regulación hacia Arriba , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA